Loss of visual acuity due to choroidal ischemia in Fabry's disease;Baisse d'acuité visuelle par ischémie choroïdienne chez un patient atteint de la maladie de Fabry

Journal Francais d'Ophtalmologie

Volumn 26, Issue 8, 2003, Pages 842-844

  Guenoun, J M ^a   Parc, C ^a   Monnet, D ^a   Brezin, A P ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Choroid; Fabry's disease; Ischemia

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CHOROID DISEASE; CLINICAL FEATURE; CONVALESCENCE; FABRY DISEASE; HUMAN; ISCHEMIA; MALE; OPHTHALMOSCOPY; RISK FACTOR; SYMPTOM; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; ANTICOAGULANTS; CHOROID; CHOROID DISEASES; FABRY DISEASE; FIBRINOLYTIC AGENTS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ISCHEMIA; MALE; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0242331303     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3-prime untranslated region. Proc Nat Acad Sci, 1988;85:3903-7.
2. Oto S, Kart H, Kadayifcilar S, Ozdemir N, Aydin P. Retinal vein occlusion in a woman with heterozygous Fabry's disease. Eur J Ophthalmol, 1998;8:265-7.
3. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA, 2000;284:2771-5.
4. Lidove O, Joly D, Barbey F, Bletry O, Grunfeld JP. Fabry disease in adulthood: clinical aspects and therapeutic progress. Rev Med Interne, 2001;22:384s-92s.
5. Iester M, Sodi A, Occella C, Vittone P. Ocular findings in Fabry's disease. Contrib Nephrol, 2001;136:260-2.
6. Dantas MA, Fonseca RA, Kaga T, Yannuzzi LA, Spaide RF. Retinal and choroidal vascular changes in heterozygous Fabry disease. Retina, 2001;21:87-9.
7. Sakuraba H, Yanagawa Y, Igarashi T, Suzuki Y, Suzuki T, Watanabe K et al. Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes. Clin Genet, 1986;29:276-83.
8. Germain DP. Maladie rare des vaisseaux, Maladie de Fabry. Sang Thrombose Vaisseaux. Vol. 13, Numéro double 8/9, Octobre-Novembre 2000: 503-512.
9. Stark, WJ. Personal Communication. Baltimore, Md., 11/16/1999.
10. Desnick RJ, Banikazemi M, Wasserstein M. Enzyme replacement therapy for Fabry disease, an inherited nephropathy. Clin Nephrol, 2002;57:1-8.